Characteristics of parental decision-making for children with advanced cancer who are offered enrollment in early-phase clinical trials: A systematic review

• Published in: Pediatric hematology and oncology 2020-08, Vol.37 (6), p.500-529
• Main Authors: Le Rouzic, Marie-Amelyne, Claudot, Frédérique
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Child; Clinical Trials, Phase I as Topic; Communication; Decision Making; Female; Humans; informed consent; Male; Neoplasms - therapy; Parents; pediatric oncology; phase I trial; Physician-Patient Relations
• ISSN: 0888-0018; 1521-0669
• DOI: 10.1080/08880018.2020.1759738

Limited research is available on parental decision-making regarding their children's participation in pediatric phase I oncology trials compared with the adult population. The objectives of this review were to describe: (1) the process of parental decision-making in this situation; (2) the optimal communication features physicians need when proposing inclusion in such trials; and (3) the place of the child/adolescent in the assent process. Thirty relevant studies meeting inclusion criteria were identified by searching five computerized databases (PubMed, Web of Science, Cairn, Psychinfo, EM Premium). Parental decision-making is a complex process based on hopeful expectations, multiple family considerations and the child's previous cancer experience. It is highly impacted by the quality of physicians' communication. A therapeutic alliance along with an empathetic attitude and a timely delivery of accurate information is essential. Due weight should be given to the voice of children or adolescents and their optimal level of involvement may be discussed depending on their age and maturity. They should be given age-adapted information in order to empower them to be rightfully and meaningfully involved in early-phase research. This review highlights the main gaps and necessary remedial actions to support an optimal patient care management in this situation. Physicians' training in communication, structured interdisciplinary teamwork and early integration of palliative care are three key challenges which need to be implemented to actively engage in optimization strategies which would improve patient care and family support when offering enrollment in a phase I trial.